MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.

Manufactures and sells transcutaneous patches, impregnated wipes, gauzes and masks

Fougera Pharmaceuticals, Inc. develops and manufactures specialty pharmaceuticals in dermatology. It operates through two core divisions: PharmaDerm and Fougera. The PharmaDerm division offers in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The company was founded in 1849 and is headquartered in Melville, NY.

R&D of pharmaceutical products.

Guangdong Qingfa Pharmaceutical Co., Ltd. (doing business as Qingfa Pharmaceutical Co. Ltd.), part of Sichuan Kelun Pharmaceutical Co., Ltd., is a Chinese company located in Meizhou. The firm manufactures drug packaging materials. It was acquired by Sichuan Kelun Pharmaceutical Co., Ltd. from Guangdong Shanwei Biology Medicine Group Co., Ltd. on January 21, 2011 for $3.67 million.

ICD Co., Ltd. engages in the manufacture of semiconductors, flat plasma display equipment, and other related products. Its products include dry etcher, evaporator, plasma asher, and others. The company was founded on February 26, 2000 and is headquartered in Anseong-si, South Korea.

Hunan Siqi Bio-Pharmaceutical Co., Ltd., established on 2001-06-14, Business scope includes biopharmaceuticals,nutritious food,Healthy food,Other unlisted food,Fruit and vegetable juice and fruit and vegetable juice drinks,Dairy drinks and vegetable protein drinks,solid drink,Manufacture of tea beverages and other beverages;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Research and development of biological products;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangxi Daqing Biotechnology Co., Ltd., established on 2014-12-02, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;Production of labor protection products;Sales of labor protection products;Sales of office equipment consumables;vending machine sales;Daily necessities sales;Health Consulting Services(Does not include medical services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;software sales;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Advertising Design,acting;advertisement making;advertising(non-broadcasting station,television station,Newspaper Publishing Unit);Information Technology Consulting Services;electronics sales;Remote Health Management Services;internet data service;Network technology service;Network and Information Security Software Development;Computer System Services;Import and export;Technology Import and Export;Disinfectant sales(Free of Hazardous Chemicals);Research and Development of Household Appliances;Mechanical equipment research and development;Hardware product development;Big data service;Home Appliance Sales;Machinery sales;Hardware retail;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Sales of infant formula milk powder and other infant formula food;Sales of formula food for special medical purposes;Sales of hygiene products and single-use medical products;Class II Medical Device Leasing;Sales of teaching models and teaching aids;Food Additive Sales;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of renewable resources;Experimental analysis instrument sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Cosmetic production;Production of hygiene products and single-use medical products;Drug retail;Internet information service;Disinfectant production(Free of Hazardous Chemicals)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

JC (Wuxi) Co. Inc. (doing business as Jesse Medicine) is a private company headquartered in Wuxi, China, that manufactures drugs.

Ixcela, Inc. operates in the healthcare industry focusing on biotechnology business. It develops diagnostic tests and natural interventions to improve gut microbiome efficacy and prevent neurodegenerative and cardiovascular diseases. The firm's technology is a proprietary biomarker discovery system integrating mass spectrometry and electrochemical arrays. The company was founded by Erika Ebbel Angle and Wayne R. Matson in 2012 and is headquartered in Bedford, MA.

Beijing Tianheng Junwei Pharmaceutical Technology Development Co., Ltd., established on 2006-10-13, Business scope includes technology development,Serve,transfer;Information Consulting;Corporate Image Planning;Organize domestic cultural and artistic exchange activities;Undertake the exhibition;Marketing Planning;Conference Services(No board and lodging);Labor service;Sales of computers and auxiliary equipment,arts and crafts,daily necessities,Wujinjiaodian,building materials,decorative material,Equipment,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),electronic product,Instrumentation,Office Supplies.[Items without administrative permission in the scope of business are excluded](Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA.

Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is a time-honored national high-tech enterprise. In December 1999, the Zhangzhou Pharmaceutical Factory established in 1956 was restructured into Pien Tze Huang Pharmaceutical. In June 2003, the company was listed on the Shanghai Stock Exchange. After two additional issues and one allotment, the company has now issued 603 million shares. Currently, the company has 34 holding subsidiaries, 8 joint -stock companies and 4 industry funds with more than 2,100 employees.

Fujian Pien Tze Huang Health Industry Co., Ltd., established on 2012-10-12, Business scope includes licensed projects:Drug Wholesale;Drug import and export;food business(Selling prepackaged food);Health food sales;Food import and export;Food Internet Sales(Selling prepackaged food);Food Internet Sales;Sales of formula food for special medical purposes;Sales of infant formula milk powder;liquor business;Class III medical device business;Import and export agency;Drug internet information service;Internet Information Service for Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engage in investment activities with own funds;Sales of Class I Medical Devices;Wholesale medical masks;Cosmetics Wholesale;Cosmetics Retail;Sales of daily chemical products;Daily necessities wholesale;Arts and crafts and collectibles wholesale(Except for ivory and its products);Arts and crafts and collectibles retail(Except for ivory and its products);Sales of Class II Medical Devices;Home Appliance Sales;Stationery Wholesale;General merchandise sales;Daily necessities sales;luggage sales;Sales of packaging materials and products;Sales of hygiene products and single-use medical products;Household Goods Sales;Personal Hygiene Sales;daily mask(non-medical)Sales;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;Disinfectant sales(Free of Hazardous Chemicals);internet sales(Except for products that require a license for sale);Information Technology Consulting Services;Information Consulting Service(Not including licensing information consulting services);marketing planning(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Engelhard Arzneimittel GmbH & Co. KG is a private company headquartered in Niederdorfelden, Germany, that manufactures and supplies pharmaceuticals. It was founded in 1872 by Karl Philipp Engelhard. Rolf Engelhard, Richard Mark Engelhard and Oliver Karl Maximillian Engelhard are the current co-CEOs of the firm.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Guangxi Innovitas Pharmaceutical Co., Ltd., established on 2018-02-28, Business scope includes licensed projects:Veterinary drug business;Veterinary drug production;Feed additive production;Cosmetic production;Health food production;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Feed Additive Sales;Cosmetics Wholesale(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Agricultural Research Council is a premier science institution that conducts research with partners, develops human capital, and fosters innovation to support and develop the agricultural sector. ARC's vision reflects its core business and recognizes its unique role as South Africa's leading agricultural research institution.

Walther Schoenenberger Pflanzensaftwerk GmbH & Co. is a German private company located in Magstadt that manufactures fruit and vegetable juices. The firm was founded in 1927. Peter Greither, Otto Greither and Florian Block are the current co-CEOs of the company.